BIOMAT Database Logo BIOMAT Database Logo

Visualization of the whole right atrium wall with Tc-99m Sestamibi scintigraphy. 2009

Mehmet Cabuk, and Sait Mesut Doğan, and Zuhal Erdem, and Duygu Yörük Atik, and Iffet Doğan
Department of Nuclear Medicine, Faculty of Medicine, Zonguldak Karaelmas University, Zonguldak, Turkey. mehmetcabuk87@yahoo.com

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006322 Heart Aneurysm A localized bulging or dilatation in the muscle wall of a heart (MYOCARDIUM), usually in the LEFT VENTRICLE. Blood-filled aneurysms are dangerous because they may burst. Fibrous aneurysms interfere with the heart function through the loss of contractility. True aneurysm is bound by the vessel wall or cardiac wall. False aneurysms are HEMATOMA caused by myocardial rupture. Cardiac Aneurysm,Aneurysm, Cardiac,Aneurysm, Heart,Aneurysms, Cardiac,Aneurysms, Heart,Cardiac Aneurysms,Heart Aneurysms
D006325 Heart Atria The chambers of the heart, to which the BLOOD returns from the circulation. Heart Atrium,Left Atrium,Right Atrium,Atria, Heart,Atrium, Heart,Atrium, Left,Atrium, Right
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015899 Tomography, Emission-Computed, Single-Photon A method of computed tomography that uses radionuclides which emit a single photon of a given energy. The camera is rotated 180 or 360 degrees around the patient to capture images at multiple positions along the arc. The computer is then used to reconstruct the transaxial, sagittal, and coronal images from the 3-dimensional distribution of radionuclides in the organ. The advantages of SPECT are that it can be used to observe biochemical and physiological processes as well as size and volume of the organ. The disadvantage is that, unlike positron-emission tomography where the positron-electron annihilation results in the emission of 2 photons at 180 degrees from each other, SPECT requires physical collimation to line up the photons, which results in the loss of many available photons and hence degrades the image. CAT Scan, Single-Photon Emission,CT Scan, Single-Photon Emission,Radionuclide Tomography, Single-Photon Emission-Computed,SPECT,Single-Photon Emission-Computed Tomography,Tomography, Single-Photon, Emission-Computed,Single-Photon Emission CT Scan,Single-Photon Emission Computer-Assisted Tomography,Single-Photon Emission Computerized Tomography,CAT Scan, Single Photon Emission,CT Scan, Single Photon Emission,Emission-Computed Tomography, Single-Photon,Radionuclide Tomography, Single Photon Emission Computed,Single Photon Emission CT Scan,Single Photon Emission Computed Tomography,Single Photon Emission Computer Assisted Tomography,Single Photon Emission Computerized Tomography,Tomography, Single-Photon Emission-Computed
D017256 Technetium Tc 99m Sestamibi A technetium imaging agent used to reveal blood-starved cardiac tissue during a heart attack. 99mTc-Hexamibi,99mTc-Sestamibi,Tc MIBI,Cardiolite,Tc-99m-Methoxy-2-isobutylisonitrile,Technetium Tc 99m 2-Methoxy-2-methylpropylisonitrile,Technetium Tc 99m Sestamibi Chloride,Technetium-99m-Hexamibi,Technetium-99m-Sestamibi,99mTc Hexamibi,99mTc Sestamibi,Tc 99m Methoxy 2 isobutylisonitrile,Technetium 99m Hexamibi,Technetium 99m Sestamibi,Technetium Tc 99m 2 Methoxy 2 methylpropylisonitrile
D019275 Radiopharmaceuticals Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161) Radiopharmaceutical

Related Publications

Mehmet Cabuk, and Sait Mesut Doğan, and Zuhal Erdem, and Duygu Yörük Atik, and Iffet Doğan
Tc-99m sestamibi scintigraphy in multiple myeloma.
February 1999, Clinical nuclear medicine,
Mehmet Cabuk, and Sait Mesut Doğan, and Zuhal Erdem, and Duygu Yörük Atik, and Iffet Doğan
Tc-99m sestamibi scintigraphy of double parathyroid adenoma.
December 1997, Clinical nuclear medicine,
Mehmet Cabuk, and Sait Mesut Doğan, and Zuhal Erdem, and Duygu Yörük Atik, and Iffet Doğan
Whole-body Tc-99m sestamibi scintigraphy in the follow-up of differentiated thyroid carcinoma.
June 2000, Clinical nuclear medicine,
Mehmet Cabuk, and Sait Mesut Doğan, and Zuhal Erdem, and Duygu Yörük Atik, and Iffet Doğan
Tumoral calcinosis demonstrated on Tc-99m sestamibi scintigraphy.
December 2008, Clinical nuclear medicine,
Mehmet Cabuk, and Sait Mesut Doğan, and Zuhal Erdem, and Duygu Yörük Atik, and Iffet Doğan
Parathyroid imaging with Tc-99m sestamibi planar and SPECT scintigraphy.
January 1999, Radiographics : a review publication of the Radiological Society of North America, Inc,
Mehmet Cabuk, and Sait Mesut Doğan, and Zuhal Erdem, and Duygu Yörük Atik, and Iffet Doğan
Tc-99m sestamibi bone marrow scintigraphy in Gaucher disease.
July 2002, Clinical nuclear medicine,
Mehmet Cabuk, and Sait Mesut Doğan, and Zuhal Erdem, and Duygu Yörük Atik, and Iffet Doğan
Megaureter visualization on Tc-99m DMSA scintigraphy.
July 2005, Annals of nuclear medicine,
Mehmet Cabuk, and Sait Mesut Doğan, and Zuhal Erdem, and Duygu Yörük Atik, and Iffet Doğan
Detection of late chest wall recurrence of breast carcinoma during Tc-99m sestamibi parathyroid scintigraphy.
May 2003, Clinical nuclear medicine,
Mehmet Cabuk, and Sait Mesut Doğan, and Zuhal Erdem, and Duygu Yörük Atik, and Iffet Doğan
False-negative scintigraphy with Tc-99m sestamibi in stage IV neuroblastoma.
April 1999, Clinical nuclear medicine,
Mehmet Cabuk, and Sait Mesut Doğan, and Zuhal Erdem, and Duygu Yörük Atik, and Iffet Doğan
Scintimammography with Tc-99m sestamibi.
January 1997, Acta medica Austriaca,
Copied contents to your clipboard!